228 related articles for article (PubMed ID: 24008862)
1. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
2. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
5. Identification and expansion of the tumorigenic lung cancer stem cell population.
Eramo A; Lotti F; Sette G; Pilozzi E; Biffoni M; Di Virgilio A; Conticello C; Ruco L; Peschle C; De Maria R
Cell Death Differ; 2008 Mar; 15(3):504-14. PubMed ID: 18049477
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD133-1 and CD133-2 in ovarian cancer.
Ferrandina G; Bonanno G; Pierelli L; Perillo A; Procoli A; Mariotti A; Corallo M; Martinelli E; Rutella S; Paglia A; Zannoni G; Mancuso S; Scambia G
Int J Gynecol Cancer; 2008; 18(3):506-14. PubMed ID: 17868344
[TBL] [Abstract][Full Text] [Related]
7. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.
Adachi M; Taki T; Huang C; Higashiyama M; Doi O; Tsuji T; Miyake M
J Clin Oncol; 1998 Mar; 16(3):1060-7. PubMed ID: 9508191
[TBL] [Abstract][Full Text] [Related]
8. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
Wei C; Guomin W; Yujun L; Ruizhe Q
Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
Berger W; Setinek U; Hollaus P; Zidek T; Steiner E; Elbling L; Cantonati H; Attems J; Gsur A; Micksche M
J Cancer Res Clin Oncol; 2005 Jun; 131(6):355-63. PubMed ID: 15856298
[TBL] [Abstract][Full Text] [Related]
12. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
[TBL] [Abstract][Full Text] [Related]
13. Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival.
Sheng B; Qi C; Liu B; Lin Y; Fu T; Zeng Q
Sci Rep; 2017 Oct; 7(1):13807. PubMed ID: 29062135
[TBL] [Abstract][Full Text] [Related]
14. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
Rountree CB; Ding W; He L; Stiles B
Stem Cells; 2009 Feb; 27(2):290-9. PubMed ID: 19008348
[TBL] [Abstract][Full Text] [Related]
15. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.
Chen YC; Hsu HS; Chen YW; Tsai TH; How CK; Wang CY; Hung SC; Chang YL; Tsai ML; Lee YY; Ku HH; Chiou SH
PLoS One; 2008 Jul; 3(7):e2637. PubMed ID: 18612434
[TBL] [Abstract][Full Text] [Related]
16. Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer.
Sasaki H; Yukiue H; Kobayashi Y; Moriyama S; Nakashima Y; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Int J Cancer; 2001 Nov; 95(6):375-7. PubMed ID: 11668520
[TBL] [Abstract][Full Text] [Related]
17. The role of PKR/eIF2α signaling pathway in prognosis of non-small cell lung cancer.
He Y; Correa AM; Raso MG; Hofstetter WL; Fang B; Behrens C; Roth JA; Zhou Y; Yu L; Wistuba II; Swisher SG; Pataer A
PLoS One; 2011; 6(11):e24855. PubMed ID: 22102852
[TBL] [Abstract][Full Text] [Related]
18. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.
Bidlingmaier S; Zhu X; Liu B
J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813
[TBL] [Abstract][Full Text] [Related]
19. Biological and genetic characteristics of tumor-initiating cells in colon cancer.
Ieta K; Tanaka F; Haraguchi N; Kita Y; Sakashita H; Mimori K; Matsumoto T; Inoue H; Kuwano H; Mori M
Ann Surg Oncol; 2008 Feb; 15(2):638-48. PubMed ID: 17932721
[TBL] [Abstract][Full Text] [Related]
20. CD133 expression is an independent prognostic marker for low survival in colorectal cancer.
Horst D; Kriegl L; Engel J; Kirchner T; Jung A
Br J Cancer; 2008 Oct; 99(8):1285-9. PubMed ID: 18781171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
